John Brendan Doyle - 01 May 2023 Form 4 Insider Report for COGNITION THERAPEUTICS INC (CGTX)

Role: Chief Financial Officer
Signature: /s/ Lisa Ricciardi, Attorney-in-Fact
Issuer symbol: CGTX
Transactions as of: 01 May 2023
Net transactions value: $0
Form type: 4
Filing time: 03 May 2023, 16:20:46 UTC
Previous filing: 05 Aug 2021
Next filing: 20 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CGTX	Common Stock	Award	$0	+109,824		$0.000000	109,824	01 May 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CGTX	Stock Option (right to buy)	Award	$0	+109,824		$0.000000	109,824	01 May 2023	Common Stock	109,824	$1.65	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
F2	The option vests 25% on May 1, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates.